Brokerages Set Capricor Therapeutics Inc (NASDAQ:CAPR) Price Target at $34.50
Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) has received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have issued ratings on the stock in […]
Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) has received a consensus recommendation of “Buy” from the six research firms that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have issued ratings on the stock in […]
